This is a "connection" page, showing publications co-authored by Daniel Brinton and Scarlett Johnson.
Assessing Health Care Utilization and Compliance in Kawasaki Disease. J Pediatr. 2021 Jul; 234:181-186.e1.
A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment. Hosp Pediatr. 2021 01; 11(1):88-93.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.